Chastened Innate Returns Lumoxiti Rights To AZ
Struggled To Commercialize Hairy Cell Leukemia Drug
Executive Summary
The French firm gave back the rights to Lumoxiti on the same day the drug got a thumbs up from the CHMP after struggling to market the rare leukemia drug in the US.